DSGN

Design Therapeutics, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
15.05
▼ 0.51 (3.28%)
MARKET ·

Price

Open
15.13
Prev close
15.56
Day high
15.83
Day low
14.98
Volume
551.77K
Market cap
$938.10M
P/E (TTM)
52W range
4.92 – 17.25

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+1.08% +2.4%
1M
+28.89% +25.2%
3M
+36.15% +33.1%
6M
+48.27% +37.2%
YTD
+59.81% +47.5%
1Y
+212.94% +192.9%
3Y
+603.76% +529.6%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$938.10M
Enterprise value$733.36M
Revenue (TTM)
Gross profit$-58.78M
EBITDA$-78.34M
Net income$-70.80M
EPS (TTM)$-1.18
Free cash flow$-32.36M
Total cash$207.40M
Total debt$2.66M
Book value / share$3.23
Shares outstanding62.58M
Float36.19M
Short % of float12.60%
Dividend yield
Beta (5Y)1.64

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-9.41
PEG ratio
Price / sales
Price / book4.65
EV / revenue
EV / EBITDA-9.36
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-34.13%
Return on assets-22.53%
Debt / equity1.32
Current ratio18.86
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2025202420232022
Total revenue$0$0$0$0
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$69.79M-$49.59M-$66.86M-$63.31M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.34-0.32 +7.1%
Mar 2026 -0.33-0.29 +13.2%
Dec 2025 -0.35-0.27 +23.7%
Sep 2025 -0.34-0.30 +12.6%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.35 7 $0 0.0%
Next quarter -0.40 7 $0 0.0%
Current year -1.36 7 $0 0.0%
Next year -1.59 7 $0 0.0%

Analyst targets & ownership

Account required
Mean target$21.00
High target$22.00
Low target$20.00
Implied upside39.53%
Analyst count6
ConsensusNONE
Strong buy / Buy2 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders31.87%
Held by institutions78.58%
Institutions holding193
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
19.94M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 13, 25
WILLIAM ARSANI H.
Director
SELL 562.63K $2.95M Indirect
Dec 18, 24
PRASAD DEEPA
Director
SELL 3.81K $23.86K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

2 reporting
NameRelationShares heldLatest
PRASAD DEEPA
Director 20.00K Sale
WILLIAM ARSANI H.
Director Sale

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
14.97
+0.54% from price
SMA 20
13.88
+8.02% from price
SMA 50
13.46
+11.35% from price
SMA 100
12.92
+16.45% from price
SMA 200
11.24
+33.40% from price
EMA 12
14.74
+2.11% from price
EMA 26
14.07
+6.96% from price
EMA 50
13.52
+11.32% from price
RSI (14)
60.2
Neutral
MACD (12,26,9)
0.67
Hist 0.16
ATR (14)
0.63
4.23% of price
Realised vol 30D
52.6%
Annualised
Bollinger upper
16.41
20, 2σ
Bollinger lower
11.35
20, 2σ
50 / 200 cross
Golden
13.46 vs 11.24
Trend bias
Above 200
+33.40%

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.20
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
52.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-35.6%
Peak to trough
Max drawdown 5Y
-92.2%
Peak to trough
ATR 14
0.63
4.23% of price
Beta (reported)
1.64
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
11.00
-26.6% from spot
ATM implied vol
136.3%
Nearest strike to spot
Skew (10% OTM)
Call volume
5
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
14.00
53 contracts
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 15.05
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.